Who Owns Adlai Nortye Group Stock?
NASDAQ: ANLHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 41.33%
- Held by insiders
- 0.94%
- Institutional holders
- 47
- Institutions 41.3%
- Insiders 0.9%
- Public and other 57.7%
Who owns Adlai Nortye Group stock?
Institutional investors own about 41.3% of Adlai Nortye Group's shares, spread across 47 institutions that file 13F reports. That level of institutional ownership is moderate. Insiders, including executives, directors and large founding shareholders, hold 0.94% of ANL.
The largest institutional holders are Cormorant Asset Management, LP (6.77%), Venrock Adviser, LLC (5.47%) and Balyasny Asset Management LP (5.21%). Together, the top 10 institutions control 34.3% of shares outstanding. In their latest filings, 9 of the top 10 institutions increased their ANL positions and 0 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of ANL
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Cormorant Asset Management, LP | 3.98M | 6.77% | +37.3% |
| Venrock Adviser, LLC | 3.21M | 5.47% | 0.0% |
| Balyasny Asset Management LP | 3.06M | 5.21% | +248.8% |
| Point72 Asset Management, L.P. | 2.14M | 3.64% | +100.0% |
| MPM Bioimpact LLC | 1.94M | 3.30% | +100.0% |
| Perceptive Advisors Llc | 1.79M | 3.05% | +100.0% |
| Casdin Capital, LLC | 1.25M | 2.13% | +132.1% |
| Adar1 Capital Management, LLC | 1.02M | 1.73% | +763.2% |
| Octagon Capital Advisors LP | 934.72K | 1.59% | +100.0% |
| Millennium Management Llc | 807.83K | 1.38% | +18.5% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of ANL
| Fund | Shares | % Held |
|---|---|---|
| MUTUAL FUND SERIES TRUST-Eventide Healthcare & Life Sciences Fund | 718.75K | 1.22% |
| Tema ETF Trust-Tema Oncology ETF | 44.35K | 0.08% |
| ETFis Series Trust I-Virtus Biotech Clinical Trials ETF | 30.12K | 0.05% |
| Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund | 17.02K | 0.03% |
| ProFunds-UltraChina ProFund | 1.16K | 0.00% |
Frequently asked questions
Who is the largest shareholder of Adlai Nortye Group?
Cormorant Asset Management, LP is the largest institutional shareholder of ANL, owning 6.77% of shares outstanding (3.98M shares) as of its latest 13F filing.
What percentage of Adlai Nortye Group is owned by institutions?
Institutions own about 41.3% of ANL shares and 41.7% of the public float.
How much of Adlai Nortye Group do insiders own?
Insiders, such as officers and directors, own about 0.94% of ANL shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.